Shimmer Adopts the V3 Framework to Validate its Verisense® Wearable Sensing Platform
CAMBRIDGE, MA – June 25, 2021 – Shimmer Research, a global leader in wearable technology for research applications, today released the initial validation paper for its Verisense® wearable sensing platform for clinical trials. This paper focuses on the Verisense IMU and...
Fulfilling the Promise of Wearables in Clinical Trials
Dublin, Ireland – June 02, 2021 Our very own Geoffrey Gill, President, Shimmer Americas, Shimmer Research Inc outlines to Pharma Voice what needs to happen at industry level, in order for wearable technology to start fulfilling its promise given its capability to...
